Notably, AAT, IGFBP2, and RAB2B expressions in pancreatic cancer patients were markedly higher relative to that in the control group while no significant differences were evident in PRDX2, RHOC, and LMNA levels in our ELISA experiments. This evidence concerns the gene PRDX2 and familial pancreatic carcinoma.